Unknown PHASE3 INTERVENTIONAL 2-arm NCT03767569

Myo-inositol as Pretreatment in Hyperandrogenic PCOS Patients

Pretreatment With Myo-inositol in Hyperandrogenic PCOS Patients Undergoing ART: a Randomized Controlled Trial

Sponsor: Universitair Ziekenhuis Brussel

Updated 5 times since 2019 Last updated: Dec 5, 2018 Started: Sep 1, 2018 Primary completion: Apr 30, 2020 Completion: Apr 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Female Infertility and PCOS, this trial is ongoing. The trial is conducted by Universitair Ziekenhuis Brussel and has accumulated 5 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
May 2020 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jan 2019 — May 2020 [monthly]

Recruiting PHASE3

First recorded

Sep 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universitair Ziekenhuis Brussel

Data source: Universitair Ziekenhuis Brussel

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium